Antiphosphatidyl serine antibodies are independently associated with ischemic stroke

Rand JH. Antiphospholipid antibody syndrome: new insights on thrombogenetic mechanisms. Am J Med Sci 1998;316:142–151.

10.1161/01.STR.21.2.295

10.1212/WNL.41.4.525

Chakravarty RK, Byron MA, Webley M, et al. Antibodies to cardiolipin and stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus. Q J Med 1991;79:397–405.

10.1212/WNL.43.10.2069

Camerlingo M, Casto L, Censori B, et al. Anticardiolipin antibodies in acute non-hemorrhagic stroke seen within six hours after onset. Acta Neurol Scand 1995;92:69–71.

10.1016/S0140-6736(94)91775-2

10.1016/0140-6736(92)91057-F

10.7326/0003-4819-117-12-997

Metz LM, Edworthy S, Mydlarski R, Fritzler MJ. The frequency of phospholipid antibodies in an unselected stroke population. Can J Neurol Sci 1998;325:64–69.

10.1161/01.STR.29.9.1759

10.1159/000109691

Toschi V, Motta A, Castelli C, et al. Prevalence and clinical significance of antiphospholipid antibodies to non-cardiolipin antigens in systemic lupus erythematosus. Haemostasis 1993;23:275–283.

Asherson RA Cervera R Piette J-C Shoenfeld Y eds. The antiphospholipid syndrome. Boca Raton FL:CRC Press 1996.

10.1056/NEJM199707173370303

10.1016/S0002-9378(97)70302-8

10.1161/01.STR.25.12.2412

10.1001/archinte.1997.00440390101013

10.1161/01.STR.28.9.1660

10.1212/WNL.48.1.91

10.1161/01.STR.29.9.1755

10.1111/j.1365-2141.1992.tb06469.x

10.1055/s-0038-1650355

10.4049/jimmunol.154.2.954

10.1016/S0002-9343(96)00254-9

10.1055/s-0038-1656102

Kittner SJ, Gorelick PB. Antiphospholipid antibodies and stroke: an epidemiological perspective. Stroke 1992;23 (suppl I):I-19–I-22.

10.1056/NEJM199504133321504

10.1159/000108175